Alexium International Group Limited · ASX:AJX
Alexium International — Shareholder Meeting (November 2022)
17 slides from Alexium International's shareholder meeting presentation, Nov 16, 2022
Slide 1: Annual General Meeting
ALEXIUM INTERNATIONAL GROUP LIMITED Annual General Meeting 16 November 2022 ABN 91 064 820 408 PRESENTED IN US DOLLARS
Slide 2: Disclaimer
Disclaimer To the maximum extent permitted by law, the information contained in this presentation is given without any liability whatsoever being accepted by Alexium International Group Limited (Alexium) or any of its related entities or their respective directors or officers, employees, advisors an
Slide 3: Company Overview
COMPANY OVERVIEW
Slide 4: Company Overview
Company Overview “Alexium’s value to customers is technology enabling them to create a unique user experience that drives higher sales volumes at improved margins…” ➢ A performance materials company leveraging proprietary technical innovations to deliver thermal regulation, dehumidification and flam
Slide 5: Alexium Management Team (effective September 1, 2022)
Alexium Management Team (effective September 1, 2022) Billy Blackburn – Chief Executive Officer/Managing Director ➢ Accomplished customer-focused executive with over 20 years of leading successful companies within the alternate fuels, specialty chemicals, and high purity solvent markets. Creative vi
Slide 6: Alexium Priorities: 3-Year Plan (FY23 - FY25)
Alexium Priorities: 3-Year Plan (FY23 - FY25) I. Alexium must deliver cash-positive results in the near-term. To do this, the company will focus most of its efforts on delivering revenue from PCM sales to traditional mattress producers II. In parallel to the above, Alexium will grow PCM sales to non
Slide 7: Alexium’s ESG Commitment
Alexium’s ESG Commitment By EOY FY2024, Alexium will SUSTAINABLE PRODUCT FOCUS: Establish baselines, metrics and KPIs for ESG performance: BiocoolTM | Alexium’s proprietary biobased cooling Environment technology for textile & foam applications ✓ Biobased, sustainable raw materials ❖ Environment: wa
Slide 8: Key Market Overview – Bedding
Key Market Overview – Bedding ➢ Since early 2022, the US bedding market has been at a 15 year low due to reduced consumer confidence ➢ Alexium has managed through this downturn by keeping inventories low, taking a J.I.T manufacturing approach, then shifting our product development focus to the top-o
Slide 9: Alexium’s Established Products
Alexium’s Established Products ➢ USDA Bio-preferred – 94% ➢ Alexium’s original PCM ➢ Customized solutions biobased content ➢ Wash durable, long-lasting ➢ Designed for use in a variety of ➢ Sustainable & affordable performance markets • Bedding ➢ Can be enhanced with additional ➢ Versatile, flexible
Slide 10: Product Update – Eclipsys for Tactical Gear
Product Update – Eclipsys for Tactical Gear ➢ First large order for Eclipsys on Body Armor in the United States scheduled for delivery in early 2023 (Dept. of Corrections) ➢ Multiple active customer product development projects ongoing with a global footprint ➢ Opportunity to retrofit existing Body
Slide 11: New Product for Thermal Comfort – DelQ
New Product for Thermal Comfort – DelQ Eclipsys INTRODUCTION TO DelQ ➢ DelQ is a new technology platform for our thermal management (TM) product portfolio. ➢ While DelQ is focused on personal thermal comfort like PCM or PCM DelQ Eclipsys, the DelQ technology is unique because it provides thermal com
Slide 12: Product Update – FR NyCo Alexiflam
Product Update – FR NyCo Alexiflam® Innovative Technology delivering wash-durable flame retardation (FR) on nylon/cotton military fabrics. The Problem: Production viable FR NyCo has been a market gap for decades Product Features: Alexiflam® ➢ Self extinguishes ➢ No melting or dripping The Solution:
Slide 13: Key Achievements, Current Milestones & Path Forward
Key Achievements, Current Milestones & Path Forward FY18-22 FY23 FY24-27 Develop Company’s Product Foundation for Profitable Deliver Meaningful Portfolio & Marketing Growth Shareholder Returns Strategies ➢ Continued revenue growth through ➢ Capitalize on globally unique and ➢ Developed broad portfol
Slide 14: FY2023: Key Milestones - Building on Alexium’s Foundation
FY2023: Key Milestones - Building on Alexium’s Foundation Leverage Alexium’s position in thermal management to saturate the mattress and top-of-bed markets Market penetration of BioCool™ products in bedding market supporting ESG goals Complete Increase Eclipsys™ applications commercialisation in the
Slide 15: Financial Results
FINANCIAL RESULTS
Slide 16: Profit and Loss Statement Spotlights
Profit and Loss Statement Spotlights Profit and loss ➢ 12% revenue growth; very strong H1 overshadowed in H2 as consumer confidence softened in the US ➢ 26% increase in gross profit and over 400 BPS increase in gross margin ➢ Operating expenses in line with prior year in a tight labor market ➢ Altho
Slide 17: Balance Sheet Spotlights
Balance Sheet Spotlights Balance Sheet Commentary ➢ Cash reduced by $1.9m with normal operating expenses, increased cash receipts and increased inventory purchases ➢ Net Working Capital increased by $0.5m due to • Decrease in A/R with a decrease in revenue • Increase in Inventory with product purcha
Alexium International Group — Shareholder Meeting (November 2022) on 6ix